Cre-LoxP: Issues Modulating Genes in the Immune System
Cre-loxP, a powerful tool for preclinical cancer research, possesses intrinsic pitfalls that can alter result accuracy according to an editorial paper in Oncoscience.
Source: forbes.com
Stay updated with breaking news from Sark Three. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Cre-loxP, a powerful tool for preclinical cancer research, possesses intrinsic pitfalls that can alter result accuracy according to an editorial paper in Oncoscience.
Understanding the role of an essential protein inside regulatory T cells could be critical in reverse-engineering a treatment for solid tumors.
Research on regulatory T cells is building towards a durable and long-lasting treatment for many solid cancers.